Journal Article (Letter)

DKFZ-2024-01195

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.

Kriegsmann, K. ; Ton, G. N. H. Q. ; Awwad, M. H. S. ; Benner, A.DKFZ* ; Bertsch, U. ; Besemer, B. ; Hänel, M. ; Fenk, R. ; Munder, M. ; Dürig, J. ; Blau, I. W. ; Huhn, S. ; Hose, D. ; Jauch, A. ; Mann, C. ; Weinhold, N. ; Scheid, C. ; Schroers, R. ; von Metzler, I. ; Schieferdecker, A. ; Thomalla, J. ; Reimer, P. ; Mahlberg, R. ; Graeven, U. ; Kremers, S. ; Martens, U. M. ; Kunz, C. ; Hensel, M. ; Seidel-Glätzer, A. ; Weisel, K. C. ; Salwender, H. J. ; Müller-Tidow, C. ; Raab, M. S. ; Goldschmidt, H. ; Mai, E. K. ; Hundemer, M.

2024
Springer Nature London

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41375-024-02290-y

Note: 2024 Jul;38(7):1621-1625

---

Contributing Institute(s):

1. C060 Biostatistik (C060)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2024

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---